MAP4K3 and systemic lupus erythematosus: Consistent with the data derived from Cohort #1, Cohort #2 patients with SLE with a higher variant frequency (>2.7%) of GLK 3′-UTR (T635C) also showed significantly decreased serum C3/C4 levels, WBC counts and platelet counts (figure 3A–D).